home / stock / fusn / fusn news


FUSN News and Press, Fusion Pharmaceuticals Inc. From 05/06/24

Stock Information

Company Name: Fusion Pharmaceuticals Inc.
Stock Symbol: FUSN
Market: NASDAQ
Website: fusionpharma.com

Menu

FUSN FUSN Quote FUSN Short FUSN News FUSN Articles FUSN Message Board
Get FUSN Alerts

News, Short Squeeze, Breakout and More Instantly...

FUSN - When (FUSN) Moves Investors should Listen

2024-05-06 09:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

FUSN - Radiopharma stocks higher as sector welcomes the latest M&A deal

2024-05-02 14:31:50 ET More on Novartis, Novartis AG, etc. Novartis AG (NVS) Q1 2024 Earnings Call Transcript Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results Novartis AG 2024 Q1 - Results - Earnings Call Presentation Novartis to b...

FUSN - Where are the Opportunities in (FUSN)

2024-04-26 16:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

FUSN - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SLCA, HCP, IP, FUSN

NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Silica Holdings, Inc. (NYSE:SLC...

FUSN - Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order

Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order Canada NewsWire HAMILTON, ON and BOSTON , April 25, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company fo...

FUSN - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN NEW YORK, NY / ACCESSWIRE / April 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fid...

FUSN - Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024 Canada NewsWire Preliminary data demonstrate FPI-2265 is active in heavily pretreated patients with progressive metastati...

FUSN - Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event

2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...

FUSN - (FUSN) Trading Signals

2024-03-27 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

FUSN - 2 More Potential Biotech Buyout Targets

2024-03-25 13:07:32 ET Summary M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related products. The oncology space continues to be a hot ...

Previous 10 Next 10